LINC00971: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Target Name: LINC00971

NCBI ID: G440970

LINC00971

Other Name(s): Long intergenic non-protein coding RNA 971 | long intergenic non-protein coding RNA 971

LINC00971: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Introduction

LINC00971 is a long non-coding RNA (lncRNA) that has been identified in various organisms, including humans. It has been characterized by its unique 3'-end, a feature that is rare in lncRNAs. LINC00971 has been shown to play a role in various cellular processes, including cell adhesion, migration, and the regulation of gene expression.

Drug Target Potential

The potential drug target for LINC00971 is its role in cell adhesion and migration. Several studies have shown that LINC00971 is involved in the regulation of tight junction formation and the maintenance of cell-cell adhesion. This is important because many diseases, such as cancer, are characterized by the breakdown of cell-cell adhesion and the ability of cells to migrate. By targeting LINC00971, researchers may be able to develop new treatments for these diseases.

Biomarker Potential

In addition to its potential as a drug target, LINC00971 may also be a useful biomarker for certain diseases. Its role in cell adhesion and migration makes it a potential candidate for use in studies of cancer progression and the effectiveness of anti-cancer drugs. Additionally , LINC00971 has been shown to play a role in the regulation of stem cell proliferation, which may make it a useful biomarker for the development of cancer stem cells.

Expression and Regulation

LINC00971 is a highly expressed gene in various organisms, including humans. It has been shown to be expressed in a variety of tissues, including brain, heart, and muscle. It has also been shown to be involved in the regulation of gene expression in various cellular processes, including cell adhesion and the regulation of cell cycle progression.

One of the unique features of LINC00971 is its 3'-end, which is composed of a repetitive sequence of nucleotides. This feature is rare in lncRNAs and is thought to play a role in the regulation of LINC00971's stability and function. Additionally, studies have shown that LINC00971 is involved in the regulation of microRNA (miRNA) expression, a process that is important for the regulation of gene expression in various cellular processes.

Functional Analysis

LINC00971 has been shown to play a role in the regulation of cell adhesion and the maintenance of cell-cell adhesion. This is important because these processes are critical for the development and maintenance of tissues and organs, including tissues used in transplantation. Additionally, LINC00971 has been shown to play a role in the regulation of stem cell proliferation, which is important for the development and maintenance of cancer stem cells.

Molecular Model and Interaction

The molecular model of LINC00971 has been proposed based on its 3'-end repeat sequence and conserved regions. In addition, analysis of the interaction network of LINC00971 revealed its role in cell-cell interactions, cell adhesion and cell migration.

Conclusion

LINC00971 is a long non-coding RNA that has been identified in various organisms, including humans. Its unique 3'-end and its role in the regulation of cell adhesion and migration make it a potential drug target and biomarker, respectively. Further studies are needed to fully understand the function and regulation of LINC00971 and its potential as a drug.

Protein Name: Long Intergenic Non-protein Coding RNA 971

The "LINC00971 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00971 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets